Patent Landscape of Countermeasures Against Smallpox and Estimation of Grant Attraction Capability Through Patent Landscape Data
We propose to use value scores for evaluation of individual patent publications/company portfolios and to use weights for assessment of technological sectors. Such a combination of automated analytical tools may lead to optimized allocation of capital and is intended to support the decisions taken by human experts.
Keywords: 4-PBA; ACAM2000; ANPs; APMV; Acanthamoeba polyphaga; Avian paramyxovirus; CEV; CF; CMX001; CTL; Chordopoxvirinae; Cidofovir; Cowpox virus; CpG ODN; DNA; Dengue fever; Deoxyspergualin; Dryvax; EC; EEV; Geldanamycin; Herpes virus; IEV; IFN; LAIC; LCR; LL-37; Lister; MVA; Modified Vaccinia virus; Monkeypox; Multi-Pathway High Throughput Assay; NCLDV; Orthopoxvirus; PCR; Plasmodium falciparum; Polyvalent vaccines; Poxiviridae; RIC; ROI; SIGA; ST-246; Tyrosine kinase; US6869793; UTI- beta; VIG (vaccinia immunoglobulines); Vaccine Adjuvants; Variola; WIPOC; WO04043490A; a-priori; antivirals; aphthous stomatitis; arrays sensors; austerity; chlorprothixene; glycoalkaloids; hemagglutinin genes; hepatitis-A; hrVCP; human BCDF; immature virion; immunological assays; immunostimulating glycopeptide; investment efficiency; mimivirus; mousepox; osteoblast; osteocyte apoptosis; patent landscape; poxvirus; prophylaxis; reverse transcriptase; smallpox; spectral analysis; technological sectors; vaccines; virokines
Document Type: Research Article
Publication date: 01 November 2010
- Recent Patents on Anti-Infective Drug Discovery publishes review articles on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content